Borkenstein & Borkenstein Private Practice, Privatklinik Der Kreuzschwestern Graz, Kreuzgasse 35, 8010, Graz, Austria.
Adv Ther. 2023 Oct;40(10):4561-4573. doi: 10.1007/s12325-023-02635-6. Epub 2023 Aug 16.
Enhanced monofocal intraocular lenses (IOLs) represent a new type of lens, which should lead to a very good distance vision similar to monofocal IOLs and an improved intermediate vision without increasing the risk for photic phenomena.
The aim of this clinical observation/registry study was to directly compare two different IOL platforms (hydrophilic acrylic L-333 (group A) vs hydrophobic acrylic AN6Q (group B)) with the same enhanced monofocal optic principle but different material and haptic design in clinical routine. A total of 102 cataract cases (51:51) were included in the study. Groups A and B were similar regarding demographics, age (71.6 ± 9 years for L-333 and 73.6 ± 8 years for AN6Q) and their calculated IOL power (20.9 ± 2.0 D for L-333 and 21.5 ± 3.4 D for AN6Q). Spherical equivalent (SE), (un)corrected distance, intermediate visual acuity, the surgeons' experience and patient feedback were assessed postoperatively.
SE improved significantly in the AN6Q group, while the L-333 group showed a slightly smaller standard deviation postoperatively. In group A the uncorrected distance visual acuity (UDVA) improved from pre-op (0.43 ± 0.16 logMAR) to 1 month post-op (0.06 ± 0.04 logMAR) significantly and in group B from pre-op (0.54 ± 0.19 logMAR) to (0.05 ± 0.06 logMAR) postoperatively. Both groups showed excellent outcomes for distance without negative side effects. On testing uncorrected intermediate vision (80 cm) with Radner charts, 80% reached line 5 (0.0 logRAD) with fewer than one mistake and 10% reached line 4 (- 0.1 logRAD) in group A; 74% reached line 5 with fewer than one mistake and 4% reached line 4 in group B.
Both IOL models (groups A and B) provided satisfying results regarding implantation behaviour, refractive error, visual acuity and overall patient satisfaction. The haptic design might influence the outcome of refractive error. Long-term follow-up data should be considered in multicentre studies to further characterize both platforms and to optimize IOL power calculation (constants, surgeon factor). It was shown that the enhanced monofocal optic can provide good visual acuity for far distance and improve intermediate distance. This type of new monofocal optic design, which however must be strictly separated from typical refractive/diffractive multifocal, presbyopia-correcting lenses, could be a good option in standard cataract care.
增强型单焦点人工晶状体(IOL)代表了一种新型晶状体,它应能提供与单焦点 IOL 非常相似的良好远视力,并改善中间视力,而不会增加产生光学现象的风险。
本临床观察/注册研究旨在直接比较两种不同的 IOL 平台(亲水性丙烯酸 L-333(A 组)与疏水性丙烯酸 AN6Q(B 组)),它们具有相同的增强型单焦点光学原理,但材料和襻设计不同。共有 102 例白内障病例(51:51)纳入本研究。A 组和 B 组在人口统计学、年龄(L-333 为 71.6±9 岁,AN6Q 为 73.6±8 岁)和计算的 IOL 度数(L-333 为 20.9±2.0 D,AN6Q 为 21.5±3.4 D)方面相似。术后评估等效球镜(SE)、(未)矫正距离、中间视力、手术医生的经验和患者反馈。
AN6Q 组的 SE 显著改善,而 L-333 组术后的标准差略小。A 组的未矫正远视力(UDVA)从术前(0.43±0.16 logMAR)改善至术后 1 个月(0.06±0.04 logMAR),B 组从术前(0.54±0.19 logMAR)改善至术后(0.05±0.06 logMAR)。两组均表现出良好的远距视力,无不良反应。在使用 Radner 图表测试未矫正中间视力(80 cm)时,A 组 80%的患者达到了 5 行(0.0 logRAD),错误少于 1 次,10%的患者达到了 4 行(-0.1 logRAD);B 组 74%的患者达到了 5 行,错误少于 1 次,4%的患者达到了 4 行。
两种 IOL 模型(A 组和 B 组)在植入行为、屈光不正、视力和整体患者满意度方面均提供了满意的结果。襻设计可能会影响屈光不正的结果。在多中心研究中应考虑长期随访数据,以进一步对这两种平台进行特征描述,并优化 IOL 度数计算(常数、手术医生因素)。研究表明,增强型单焦点光学可提供良好的远视力,并改善中间距离视力。这种新型单焦点光学设计可作为标准白内障护理的一种选择,与典型的屈光/衍射多焦点、老视矫正型晶状体严格区分。